TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ: 200230)

TELCON RF PHARMACEUTICAL. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 6, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	71,910	97,673	110,233	255,964	517,387	404,261
Market Cap Growth	-19.46%	-11.39%	-56.93%	-50.53%	27.98%	-40.70%
Enterprise Value	108,675	107,951	136,288	323,257	529,065	411,692
Last Close Price	5980.00	8730.00	10150.00	29250.00	60600.00	48600.00
PE Ratio	-	7.02	-	-	-	-
PS Ratio	1.89	2.69	3.96	6.76	15.61	7.14
PB Ratio	0.76	0.93	1.31	2.40	5.66	3.57
P/TBV Ratio	0.94	1.18	1.83	3.35	8.74	5.29
P/FCF Ratio	-	-	-	-	309.62	99.68
P/OCF Ratio	42.18	-	-	-	184.59	80.65
EV/Sales Ratio	2.94	2.97	4.90	8.54	15.96	7.27
EV/EBITDA Ratio	28.43	20.72	623.83	-	229.33	55.80
EV/EBIT Ratio	-	111.83	-	-	-	139.74
EV/FCF Ratio	-40.82	-	-	-	316.61	101.51
Debt / Equity Ratio	0.45	0.26	0.36	0.52	0.97	0.11
Debt / EBITDA Ratio	11.67	5.26	138.58	-	38.28	1.65
Debt / FCF Ratio	-	-	-	-	52.85	3.00
Asset Turnover	0.26	0.28	0.19	0.21	0.21	0.36
Inventory Turnover	5.01	5.57	4.99	6.71	6.12	9.56
Quick Ratio	0.17	0.56	0.47	0.55	0.39	1.93
Current Ratio	0.31	0.94	0.67	0.62	0.44	2.23
Return on Equity (ROE)	-10.43%	14.75%	-44.16%	-23.10%	-40.73%	-40.93%
Return on Assets (ROA)	-0.32%	0.46%	-1.77%	-1.62%	-0.83%	1.18%
Return on Capital (ROIC)	-0.34%	0.49%	-1.83%	-1.67%	-0.86%	1.23%
Earnings Yield	-14.42%	14.24%	-38.18%	-9.02%	-7.90%	-13.56%
FCF Yield	-3.70%	-5.07%	-2.64%	-1.02%	0.32%	1.00%
Buyback Yield / Dilution	17.91%	-8.89%	-56.33%	-2.64%	-3.29%	-7.53%
Total Shareholder Return	17.91%	-8.89%	-56.33%	-2.64%	-3.29%	-7.53%

Source: S&P Capital IQ. Standard template. Financial Sources.